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We have characterized viral –cell interactions of hepatitis C virus (HCV) and liver cells to study the pathogenesis of HCV
infection. HepG2 cells constitutively expressing HCV core protein showed apoptotic changes in response to stimulation
with anti-Fas monoclonal antibody. Cells treated with the antibody showed extensive cell rounding, shrinkage, and cyto-
plasmic blebbing and finally detached from plates. Fragmentation of the chromatin was observed in the nucleus and DNA
ladders were detected. In contrast, cells expressing HCV envelope, nonstructural proteins or normal HepG2 cells did not
exhibit such Fas-mediated apoptosis. However, expression of Fas receptor was not upregulated on the surface of the cells
expressing HCV core protein. Apoptotic cell death was prevented by pretreatment with a specific inhibitor of the cysteine
protease CPP32, while the specific inhibitor of interleukin-1b-converting enzyme did not show the preventive effect. The
results suggest (i) that intracellular expression of HCV core protein makes cells prone to apoptotic death without upregulation
of surface Fas expression and (ii) that the CPP32 protease plays a part in the apoptosis effector pathway of HCV core-
expressing cells. HCV core protein may have a role in immune-mediated liver cell injury. q 1997 Academic Press
core protein may transform rat embryo fibroblasts in co-INTRODUCTION
operation with ras oncogene (Ray et al., 1996).
Hepatitis C virus (HCV) is a positive strand RNA virus, Apoptotic cell death plays an important role in the
belonging to the Flaviviridae family. It is a major caus- cytopathogenicity induced by several viruses (Hinshaw
ative agent of parenterally transmitted non-A non-B hepa- et al., 1994; Kawanishi, 1993; Laurent-Crawford et al.,
titis (Choo et al., 1989). A main characteristic feature 1993; Ubol et al., 1996). For example, Jeurissen et al.
of HCV infection is its persistent nature and the high (1992) have shown that the virus-induced apoptosis is
frequency of chronicity. Chronic hepatitis may evolve into responsible for depletion of thymocytes in young chick-
liver cirrhosis and also into hepatocellular carcinoma ens infected with chicken anemia virus. In acute human
(Saito et al., 1990). immunodeficiency virus (HIV) infection, low-molecular-
Although immunologically mediated and virus-induced weight DNA accumulates in the nucleoplasm of infected
mechanisms have been proposed, the pathogenesis of cells, indicating that cytopathic effects of HIV are associ-
HCV-associated liver damage is not well understood yet. ated with apoptosis (Laurent-Crawford et al., 1991).
The lack of an efficient replication system for HCV in cell In the case of hepatitis, however, involvement of
culture has hampered the determination of whether HCV apoptosis in its pathogenicity is not clear. So far only
proteins have any direct roles in the immune-mediated histochemical examinations of biopsy samples from pa-
liver cell damage and in the viral persistence. tients with viral hepatitis have been reported to show
Nucleotide sequences of the gene coding for HCV core apoptosis of hepatocytes (Kerr et al., 1979). Fas-mediated
protein are well conserved among strains obtained from apoptosis of hepatocytes has been recently suggested
various parts of the world (Bukh et al., 1994). Antibodies by detecting Fas antigen in the liver tissue with infiltrating
to core protein are most frequently detected in patients mononuclear cells in patients with hepatitis C (Hiramatsu
and carriers infected with HCV (Chiba et al., 1991). Fur- et al., 1994). It is thus important to examine whether
thermore, data have been accumulating to suggest that apoptotic pathways account for the liver cell damage in
in addition to functioning in the formation of nucleocap- acute and chronic hepatitis.
sids the HCV core protein has a regulatory function for We have established various liver cell lines constitu-
other gene expression (Kim et al., 1994; Shih et al., 1993; tively expressing HCV proteins to study viral– cell interac-
Ray et al., 1995). It is also recently reported that HCV tions in HCV-infected cells (Harada et al., 1995a,b). When
tested in HepG2 cells, the expression of HCV core pro-
tein appeared to downregulate the cell growth (Harada
1 Permanent address: Department of Virology, Istituto Superiore di and Matsuura, unpublished observations). The HepG2Sanita’, Viale Regina Elena 299, 00161-Rome, Italy.
cells constitutively expressing HCV core protein showed2 To whom correspondence and reprint requests should be ad-
dressed. Fax: 81-3-5285-1161. E-mail: tmiyam@nih.go.jp. extensive cytoplasmic vacuoles containing apolipopro-
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tein (Barba et al., in press). Hepatitis is considered to be dene difluoride membrane (Immobilon, Millipore Ltd., Ja-
pan). After blocking in nonfat milk solution (Block Ace,the sum total of phenomena of viral– cell interactions in
liver cells, and the above data are suggestive of HCV Yukijirushi Co., Sapporo, Japan), the membrane was
probed with HCV anti-core monoclonal antibody (Suzukicore protein’s role in the apoptotic pathway.
To investigate the effects of intracellular HCV core et al., 1995) as primary antibody and incubated for 1 hr
at 377. After being washed, the membrane was furtherprotein in relation to Fas-mediated apoptosis, we studied
the susceptibility of the HepG2 cell line constitutively incubated with horseradish peroxidase-conjugated
sheep anti-mouse immunoglobulins as secondary anti-expressing HCV core protein to anti-Fas antibody.
body. Antigen – antibody complexes were visualized by
enhanced chemiluminescence detection system (ECL,MATERIALS AND METHODS
Amersham International, Buckinghamshire, England) ac-
Cells and plasmids cording to the manufacturer’s protocol.
To establish HepG2, a human hepatoblastoma cell
Indirect immunofluorescence analysisline, constitutively expressing HCV core protein, cells
were transfected with the plasmid pcEF39neo. The plas- After being washed with phosphate-buffered saline
mid carries the cDNA coding for HCV core protein (amino (PBS), cells were fixed with methanol– acetone (1:1 v/v)
acid position 1– 194) (Takeuchi et al., 1990) under the for 10 min at 0207. Fixed cells were incubated with
control of the EF1-a promoter (Uetsuki et al., 1989). Cells mouse monoclonal antibodies raised against HCV core
were also transfected with the expression vector pcEF32- E1 and E2 proteins diluted to 1:100 in PBS for 60 min at
1swxneo as a negative control (Kim et al., 1994; Harada 207. The secondary antibody was fluorescein isothiocya-
et al., 1995b). HepG2 cells constitutively expressing HCV nate (FITC)-conjugated goat anti-mouse IgG (TAGO, Bur-
E1– E2 proteins or nonstructural proteins were obtained lingame, CA) diluted to 1:100 in PBS. Cells were incu-
by transfecting cells with the plasmids pcEF827 and bated for a further 30 min before observation.
pcEF3269 carrying the HCV coding regions correspond-
ing to amino acid positions 155– 810 (E1– E2) and 974– Fluorescent ELISA immunoassay
2212 (from the C-terminal of NS2 to the N-terminal half of
HCV core protein expressed in each cell clone wasNS5A), respectively (Harada et al., unpublished, 1995b).
quantitated by fluorescent ELISA immunoassay (FEIA)HepG2 cells were maintained in Dulbecco’s modified
(Tanaka et al., 1995). For FEIA 105 cells were lysed inEagle’s medium (DMEM)-F12 supplemented with 10% fe-
TNE buffer [10 mM Tris – HCl (pH 7.8), 150 mM NaCl, 1tal bovine serum, 2 mM glutamine, 100 IU/ml of penicillin,
mM EDTA, 1% NP-40] and then processed accordingand 100 mg/ml of streptomycin and plated on collagen-
to the manufacturer’s instruction (International Reagentscoated dishes. Cells were transfected by calcium phos-
Co., Kobe, Japan). The relative fluorescence intensity wasphate precipitation method (Pharmacia Biotech, Tokyo,
determined by ELSIA-F3000 reader.Japan), as previously described (Harada et al., 1995b).
After transfection transformants were selected in DMEM-
Anti-Fas antibody and proteases inhibitors treatmentF12 medium containing 1 mg/ml of G418 (Gibco BRL,
Gaithersburg, MD). The isolated G418-resistant colonies To test the cytocidal effect of anti-Fas, each estab-
were designated Hep39 (expressing core protein), lished cell line was treated for 24 hr with 0.25 mg/ml of
Hepswx (transfected with expression vector), Hep827 anti-human Fas mAb in culture medium containing 2%
(expressing E1 and E2 proteins), and Hep3269 (express- FCS. Three clones of Hep39 cells and one respective
ing nonstructural proteins; Harada et al., 1995b). clone of Hep827 and Hep3269 cells were tested. Hepswx
and untransfected HepG2 cells were also tested as neg-
Reagents ative controls.
To examine the effect of the apoptosis inhibitors,A murine anti-human Fas monoclonal antibody, CH-11
Hep39 cell lines were pretreated for 2 hr with 100 mMclone (anti-Fas mAb) (Yonehara et al., 1989), was pur-
either Ac-YVAD-cho or Ac-DEVD-cho. Cells were furtherchased from MBL, Nagoya, Japan. The tetrapeptides Ac-
incubated at 377 with anti-Fas mAb (0.25 mg/ml) for 24YVAD-cho (specific inhibitor of interleukin-1b-converting
hr in the presence of each inhibitor.enzyme) and Ac-DEVD-cho (specific inhibitor of CPP32/
apopain) were purchased from Peptide Institute, Inc.,
Nuclear stainingOsaka, Japan.
For detection of changes in nuclear chromatin, cellsImmunoblotting analysis
were fixed in methanol – acetic acid (3:1 v/v) for 10 min at
0207. The cell nuclei were stained with 4*,6*-diamidino-2-Expression of core protein was detected by Western
blotting. Cell lysates from 106 cells were separated by phenylindole (DAPI) (0.1 mg/ml in PBS) for 5 min in the
dark. After washing in PBS, nuclear samples were12.5% SDS – PAGE and electrotransferred to polyvinyli-
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mounted in Mowiol (Calbiochem-Novabiochem Co., La RESULTS
Jolla, CA) and visualized under a fluorescence micro-
Expression of HCV proteins in stable transfectantsscope with a uv filter.
Expression of HCV core protein in stable transfectants
was examined by immunoblot analysis. Figure 1A showsDNA fragmentation assay
the expression of 22-kDa HCV core protein detected in
three different clones of established Hep39 cells. TheFor DNA fragmentation analysis, adherent and floating
molecular weight of the detected protein is in agreementcells were harvested and washed in PBS. Total DNA was
with that reported for HCV capsid protein in mammalianextracted by incubating cells in 10 mM Tris – HCl (pH 8.0)
and insect cells (Harada et al., 1991; Suzuki et al., 1995).containing 10 mM EDTA and 0.5% Triton X-100, for 5 min
HCV core protein was localized in the cytoplasm of allon ice. After centrifugation at 12,000 rpm for 15 min at
Hep39 clones examined, as determined by immunofluo-47, the supernatants were incubated with RNase A (5
rescence (Fig. 1B, a). We further quantitated HCV coremg/ml, Sigma, Miyata Kagaku, Tokyo, Japan) overnight at
protein expressed in each cell line by FEIA (Tanaka et377, followed by 2 hr incubation at 507 with proteinase K
al., 1995). Expression levels of HCV core protein in cell(200 mg/ml, Sigma) and 0.5% SDS. After extraction with
clones were almost the same (Fig. 1A). Expression levelsphenol/chloroform, fragmented DNA was precipitated
of other HCV proteins in other stable transformants werewith ethanol and 5 M NaCl and analyzed by 1.5% agarose
also examined by immunofluorescence analysis. Al-gel in TBE buffer. DNA fragmentation was analyzed for
though the staining was not as bright as that of corethree clones of both Hep39 and Hepswx cell lines and
protein in Hep39 cells, both E1 and E2 proteins werefor HepG2 cells under identical conditions, after 24 hr
detected in almost all Hep827 cells (Fig. 1B, b and c).incubation with anti-Fas antibody.
Immunofluorescence analysis of nonstructural proteins
in Hep3269 was reported previously (Harada et al.,
Analysis of apoptosis by flow cytometry
1995b).
For flow cytometry analysis of cells undergoing apo-
Sensitivity to Fas-mediated apoptosis of Hep39ptotic death after treatment with anti-Fas antibody, adher-
ent and floating cells were pooled and washed with cold To examine the susceptibility of HepG2 cells express-
citrate buffer (250 mM sucrose, 40 mM trisodium citrate, ing HCV core protein to Fas-mediated apoptosis, cells
20% DMSO). Cell pellets were incubated for 10 min at were treated with anti-Fas mAb, as described under Ma-
room temperature (RT) with 0.03% trypsin solution con- terials and Methods. Apoptotic cell death was evaluated
taining 3.4 mM trisodium citrate, 1.5 mM spermine, 0.5 on the basis of morphological and nuclear changes of
mM Tris, and 0.01% NP-40 (pH 7.6). The samples were cells, nuclear DNA fragmentation, and flow cytometry
further incubated for 10 min after addition of trypsin inhib- analysis. We found that interaction of Fas with anti-Fas
itor (0.5 mg/ml, Sigma) and RNase A (0.1 mg/ml, Sigma). antibody induced marked apoptosis in HCV core-ex-
Cells were then stained with propidium iodide (0.4 mg/ pressing HepG2 cell lines, while it failed to induce apo-
ml) for 10 min at RT. The samples were analyzed by a ptotic cell death in control Hepswx and HepG2 cells.
FACScan flow cytometer (Becton– Dickinson, USA). Apo- From 5 to 8 hr after treatment with anti-Fas antibody,
ptotic cells were analyzed by Lysis II program and the cells expressing core protein started to round up and
data from 10,000 cells for each sample are shown in lose contacts with neighboring cells. After 24 hr cells
tridimensional view. displayed severe shrinkage together with cytoplasmic
blebbing. Most of the apoptotic cells were detached from
the plate and were floating in the medium (Fig. 2). WeAnalysis of Fas expression on cell surface
also stimulated HepG2 transformant cell lines with vari-
ous monoclonal antibodies to examine their interactions.The expression of Fas antigen on HepG2, Hepswx,
and Hep39 cells was analyzed by flow cytometry using We used antibodies to MHC class I, IL-6 receptor and
CD54 which were all well-expressed on the surface ofthe mouse anti-human Fas mAb (CH-11) as primary anti-
body. Adherent cells were detached and washed with those cell lines. No apparent apoptosis was observed in
cells treated with those antibodies after 24 hr of incuba-DMEM-F12 medium containing 2% FCS. Aliquots of 106
cells were incubated with 20 mg/ml of CH-11 mAb for 30 tion (data not shown).
Nuclear staining with DAPI showed condensed chro-min on ice. After washing, cells were incubated with
FITC-conjugated goat anti-mouse immunoglobulins (Bio- matin at the periphery of the nuclear membrane and
fragmentation of chromatin into small round bodies, char-source International, Inc., Tago Products, USA) as sec-
ond antibody for further 30 min on ice. After final washing acteristic of apoptotic nuclei (Fig. 3). In contrast, cells
transfected with the expression vector alone or untrans-cells were analyzed by a FACScan flow cytometer (Bec-
ton– Dickinson). fected HepG2 cells did not show any signs characteristic
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FIG. 1. Expression of HCV proteins in stable transformants. (A) Detection of HCV core protein in stable transformants by immunoblot analysis.
22-kDa HCV core protein detection is shown in three clones of Hep39 cells (clone Nos. 1, 2, and 3); three clones of Hepswx (clone Nos. 1, 2, 3)
are shown as negative control. The numbers at the bottom indicate the expression levels of HCV core protein (ng/105 cells) in each clone of Hep39
cells detected by FEIA. (B) Indirect immunofluorescence of HCV structural proteins. Hep39 (a), Hep827 (b, c), and Hepswx cells (d, e, f) were fixed
and incubated with monoclonal antibodies against core (a, d), E1 (b, e), and E2 (c, f) proteins. HCV proteins were visualized with FITC-conjugated
anti-mouse IgG.
FIG. 2. Representative morphology of apoptotic Hep39 cells (A) and control Hepswx cells (B) 24 hr after incubation with anti-Fas antibody (CH-
11).
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FIG. 3. Nuclear morphology of Hep39 (A) and control Hepswx cells (B) visualized by DAPI staining. The arrows indicate nuclei of Hep39 cells
fragmented in small round bodies. The stained nuclei were visualized under a fluorescence microscope with a UV filter.
of apoptotic morphology after anti-Fas treatment (Fig. 2B level. Hep39 cell culture exhibited high levels of apoptotic
and Fig. 3B). Detection of apoptotic changes in all three cells (44– 55%), whereas the control Hepswx cell lines
clones of Hep39 cells examined indicated that sites of showed only background levels of apoptosis (11%) under
integration in stable transformants of Hep39 cells did not identical conditions. Cells expressing core protein in the
influence their response to anti-Fas mAb. absence of stimulation with anti-Fas antibody did not
Although some exceptional cases have been de- show any apoptosis. HepG2 cells constitutively express-
scribed where apoptotic death occurs in the absence of ing HCV envelope proteins, Hep827, and nonstructural
DNA fragmentation (Oberhammer et al., 1993), internu- HCV proteins, Hep3269, indicated low levels of apoptosis
cleosomal degradation of DNA, characterized by the ap- (5 and 13%, respectively), not significantly different from
pearance of DNA ladders due to activation of nuclear controls. This is consistent also with the lack of morpho-
endonucleases, is considered a hallmark of cells under- logical and nuclear apoptotic changes in HepG2 cells
going apoptosis (Willie et al., 1982). In Hep39 cells, deg-
radation of DNA produced typical oligonucleosomal DNA
ladders after anti-Fas treatment in all clones (Fig. 4). In
contrast, control and untransfected HepG2 cells did not
show any degradation of the DNA under identical condi-
tions.
Apoptosis rates on flow cytometry analysis
Rates of apoptosis after anti-Fas treatment were deter-
mined by the appearance of hypodiploid DNA peaks on
propidium iodide (PI) staining and flow cytometry analy-
sis (Fig. 5). Apoptotic cells in the sub-G0/G1 region were FIG. 4. DNA fragmentation in cells treated with anti-Fas. DNA ladders
detectable only in HCV core-expressing cells, whereas were analyzed for three clones of both Hep39 and Hepswx cell lines
Hep827 and Hep3269 cells, as well as controls, did not and for HepG2 cells under identical conditions; lane M contained the
100-bp DNA ladder (Gibco BRL).show any clear apoptotic population above background
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TABLE 1
Expression of Surface Fas Antigen in HepG2 Cells Constitutively
Expressing HCV Core Proteina
Fas-positive Intensity of surface
cells (%) Fas expression (mean)
HepG2 88 28
Hepswx 81 26
Hep39 92 30
a The values shown are representative of three experiments and of
three different clones of Hep39 and Hepswx cell lines.
Analysis of apoptotic effector pathway in Hep39 cells
It has recently been demonstrated that interleukin-1b-
converting enzyme (ICE) (Kuida et al., 1995) and several
other identified ICE-like cysteine proteases are involved
in the effector pathway of apoptosis (Fernandes-Alnemri
et al., 1994; Tewari et al., 1995; Nicholson et al., 1995).
To investigate the possible involvement of ICE or an ICE-
FIG. 5. Flow cytometry analysis of apoptotic cells. The samples were like protease, CPP32/apopain, in Fas-mediated apoptotic
analyzed by a FACScan flow cytometer (Becton–Dickinson Immunocy-
death of Hep39 cells, we examined the effect of twotometry Systems) after propidium iodide staining as described under
tetrapeptides, Ac-YVAD-cho and Ac-DEVD-cho, whichMaterials and Methods. The percentage of apoptotic cells in the sub
G0/G1 region, after incubation with anti-Fas antibody, was analyzed for specifically inhibit ICE and CPP32 proteases, respec-
untransfected HepG2 cells, Hepswx cells, Hep39 cells not treated with tively. In the presence of Ac-DEVD-cho, the level of apo-
anti-Fas (control), three clones of HepG2 cells expressing core protein ptotic cells in the sub-G0/G1 population was of the same(Hep39 Nos. 1, 2, and 3), cells expressing HCV envelope proteins
order as the background level (7%), whereas in the pres-(Hep827), and cells expressing HCV nonstructural proteins (Hep3269).
ence of Ac-YVAD-cho, the percentage of hypodiploidThe numbers in parentheses indicate the percentage of apoptotic cells,
detected by hypodiploid DNA peaks. cells was much higher than the background level (20%)
(Fig. 6). It was close to the levels of apoptosis in Hep39
cells treated with anti-Fas in the absence of any protease
harboring HCV envelope or nonstructural proteins. These
cells and the controls (Hepswx and HepG2) did not show
apoptotic cell death even when cells were treated with
higher concentration (0.5 mg/ml) of anti-Fas antibody. In
Hep39 cells, however, 0.1 mg/ml of the antibody was
sufficient to induce apoptotic changes (data not shown).
Expression of surface Fas antigen
We then examined the association between Fas anti-
gen expression on the cell surface and intracellular pres-
ence of HCV core protein by flow cytometric analysis
using anti-Fas mAb. The number of cells expressing Fas
antigen was not significantly different in core-expressing
cells (92%) compared to those of the controls, HepG2
and Hepswx (88 and 81%, respectively) (Table 1). In addi-
tion, the expression levels of surface Fas did not show
significant changes between Hep39 cells (intensity of
surface Fas: 30) and controls (intensity of surface Fas:
FIG. 6. Inhibition of Fas-mediated apoptosis by Ac-YVAD-cho or Ac-26). This means that the levels of Fas antigen on the cell
DEVD-cho. Adherent and detached cells were pooled and processedsurface are not influenced by the presence of intracellu-
for flow cytometry analysis. Histograms are presented for untreatedlar HCV core protein. It also indicates that neither the
Hep39 cells (control), Hep39 cells incubated with anti-Fas antibody in
number of Fas antigen-positive Hep39 cells nor the ex- the absence of any inhibitor, and Hep39 cells treated with anti-Fas in
pression levels of surface Fas antigen correlated with the presence of either Ac-DEVD-cho or Ac-YVAD-cho. The histograms
are representative of analyses performed in triplicates.anti-Fas-induced apoptosis in Hep39 cells.
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inhibitor (30%). Fas-mediated apoptosis of HepG2 cells apoptotic cell death may account for the liver cell damage
observed in acute and chronic hepatitis. Apoptosis of hepa-harboring HCV core protein was prevented by Ac-DEVD-
cho, but not by Ac-YVAD-cho. tocytes in viral hepatitis may also give clues to understand
the discordance between serum transaminase values and
the degree of histological injury (Que et al., 1996).DISCUSSION
Apoptosis under physiological cell conditions is a two-
phase process. In the first phase, even if they look nor-In spite of the lack of an in vitro cell system to support
the efficient replication of HCV, the constitutive expres- mal, cells are committed to undergo apoptotic death in
response to various stimuli. In the second phase ofsion of viral proteins in human hepatoma cell lines pro-
vides useful information for studying the effects induced apoptosis cells undergo dramatic morphological and
physiological changes, culminating in cell death (Stellerby expression of HCV proteins. Here we report the effect
of intracellular HCV core protein in relation to Fas-medi- et al., 1995). With respect to this concept, the sensitivity
to anti-Fas-triggered apoptosis in Hep39 cells describedated apoptosis.
Data have been accumulating to suggest that HCV here is considered in that the Fas transduction pathway
is primed to induce apoptosis in HepG2 cells harboringcore protein is a trans-acting regulatory protein. The 22-
kDa core protein trans-suppressed CAT gene expression certain intracellular HCV protein. The results, together
with the lack of apoptotic cell death in HepG2 cells con-under the control of various promoters (Kim et al., 1994).
It was reported to regulate the replication and the expres- stitutively expressing other HCV proteins like envelope
or nonstructural proteins, strongly indicate a role for HCVsion of the HBV genome (Shih et al., 1993) and to trans-
activate c-myc oncogene (Ray et al., 1995). HCV core core protein in making cells prone to undergo apoptosis.
Therefore, core protein may have an indirect role in medi-protein enhanced the H-ras oncogene activity in immor-
talizing rat embryo fibroblast (Ray et al., 1996). These ating HCV-induced liver cell damage and in the proposed
immune-mediated cytopathogenicity.observations suggest that HCV core protein functions
not only as a structural nucleocapsid protein but also as The lack of a significant difference in the expression
level of surface Fas antigen between Hep39 and controla regulatory protein of gene expression.
Apoptosis, a cellular genetic program leading to cell Hepswx and HepG2 cells suggests that expression lev-
els of Fas antigen on the cell surface can be dissociatedshrinkage, cytoplasmic blebbing, and cleavage of chro-
mosomal DNA, is a cellular response to various stimuli. from its mediation of an apoptotic effect. Furthermore, it
indicates that the apoptotic priming effect of HCV coreBoth physiological and pathological stimuli including vi-
ral infections induce apoptosis (see Vaux and Strasser, protein is not associated with the upregulation of surface
Fas antigen. The independence of apoptosis priming1996, for review). The mechanisms by which a virus acti-
vates the apoptotic pathway in infected cells are not from Fas antigen expression level in Hep39 cells sug-
gests that the apoptosis effector pathway located down-known. Although intracellular synthesis of viral proteins
is generally required, expression of single viral protein stream of the surface Fas is affected by HCV core protein.
Such an effect of HCV core protein makes the cells highlymay be sufficient. Apoptosis, for instance, is associated
with chicken anemia virus VP3 protein (Noteborn et al., susceptible to anti-Fas antibody.
Protease activity has been described to have a promi-1994) and with human T-cell leukemia virus Tax protein
(Yamada et al., 1994). Fas agonists induced typical nent role in apoptotic cell death (see Seamus and Doug-
las, 1995, for review). In mammalian cells, the ICE familyapoptosis in primary T lymphocytes from HIV-infected
patients and in CD4/ cell lines expressing viral gp160 of proteases includes at least seven recently identified
members, whose prototypes are ICE, CPP32, and Ich-1(Estaquier et al., 1996; Lu et al., 1994).
In addition to direct viral cytotoxicity, apoptotic cell death (Duan et al., 1996). Inhibition by Ac-DEVD-cho peptide
indicates that Fas-mediated apoptosis in Hep39 cellsduring viral infection can occur as a result of an immune
response mediated by cytotoxic T lymphocytes (CTL). Since involves the preferential activation of CPP32. Moreover,
this result suggests that the apoptotic machinery ofliver cells were shown to be sensitive to induction of
apoptosis by agonists of Fas antigen both in primary human Hep39 cells shares the effector pathway of the Fas-in-
duced death signal reported for other cell systems, suchhepatocytes in vitro (Galle et al., 1995) and in murine model
in vivo (Ogasawara et al., 1993), the release of soluble Fas as some T lymphoid cells. In addition, as CPP32 activa-
tion has been shown to be a downstream event in theligand into systemic circulation from activated CTLs may
contribute to the hepatocyte injury (Que et al., 1996). In fact, apoptotic pathway (Greidinger et al., 1996), commitment
to apoptosis mediated by HCV core protein may involvethe expression of Fas antigen was shown in the liver tissue
in patients with hepatitis C, with a higher prevalence in an upstream event(s) which is not known yet.
In conclusion, by stimulation with anti-Fas antibody,regions of active inflammation (Hiramatsu et al., 1994).
Moreover, expression of Fas ligand was reported in liver- we could demonstrate apoptotic cell death in a human
hepatoma cell line constitutively expressing HCV coreinfiltrating mononuclear cells in patients with hepatitis C
(Mita et al., 1994). From the observations described above, protein. This may help to explore the new aspects of
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structural proteins of hepatitis C virus by transfection of viral cDNA.virus– cell interaction to understand the pathogenicity of
J. Gen. Virol. 76, 1215–1221.HCV infection.
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